How Younger Patients With Colorectal Cancer Symptoms Can Be Better Self Advocates

Video

Young-onset colorectal cancer is sometimes hard for patients to talk about due to stigma, but one oncologist discusses how patients can be better self-advocates.

Many younger patients with signs or symptoms of colorectal cancer (CRC) describe being “brushed off” by their doctors on the first visit, leading to many early-onset cases that have reached an advanced stage by the time they are diagnosed; this, in turn, makes the cancers more difficult to treat. That’s why it’s important that individuals feel empowered to talk with their doctors about any health concerns they may have, even if they are younger or appear healthy, says Dr. Mark Lewis of Intermountain Healthcare.

In an interview with CURE® in which he discussed actor Chadwick Boseman’s death from the disease, Lewis went on to explain the consequences that younger patients may face as a result of a lack of shared decision making with doctors. Lewis concluded with advice on how patients can work with their health care teams to be better advocates for themselves and get testing when it's needed.

Transcription:

Yes, they do tend to present at a later stage, meaning the cancer is more advanced at the time of diagnosis. So even though, on the whole, they're younger, and aside from the cancer healthier than some of their older counterparts, that unfortunately sort of levels the playing field for them. And they seem to actually sometimes do worse than you'd expect, just based on their chronologic age. So, the fact that your question is two parts is perfect, because I think it requires basically a two-pronged approach.

We're clinicians, including my colleagues in primary care, and my wife is a primary care pediatrician, and they have an enormous challenge to sort of discern who's really sick from the well, among their patients undergoing health maintenance. So, those physicians have to be aware, this is a growing problem, and sort of have their antennae up for that.

But then I also think there's nothing more powerful than a patient who advocates for themselves, and that can be particularly difficult for a young person. Hopefully, we're not too intimidating as doctors, but I still think there's this notion that somehow we are paternalistic and we're going to tell you what to do. Increasingly, that paradigm is going away, and we're a lot more about making decisions together. It's even called shared decision making.

So, I think it's really important, especially if you only have a short period of time with your doctor for an annual checkup, that you really bring to the forefront things that are concerning you and that are hard to talk about.

You know, in my experience, young people, particularly young men, don't really want to talk about rectal bleeding. But it's important that you bring things up like, obviously blood lost in the stool, but even unexplained abdominal pain, changes in your weight, changes in stool caliber; these are all, unfortunately, signs that often are either suppressed by the patient or overlooked by the doctor or both. And you're absolutely right that the tendency to think that a young person must be healthy based on your age, unfortunately, that notion has been severely challenged by tragic examples like Chadwick Boseman’s, and it really calls for more attentive diagnosis.

Lastly, in answering your question, I want to draw a distinction between screening and diagnostic procedures. Screening is almost governed exclusively by age and a little bit by family history. Diagnosis, however, is when you go to your physician and say, ‘I have XYZ complaints,’ and then they launch an investigation as to why that's happened to you. Those are completely distinct. So, coverage for screening is quite different, actually, than coverage for diagnosis. So, it's really important that patients advocate for themselves and that a doctor secures the appropriate coverage.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Dr. Giles in an interview with CURE